The author Announces the Publication of its Procurement Research Report – Global Pharmaceutical Drug Development Services Category - Procurement Market Intelligence Report 2019-2024.
The author recognizes the following companies as the key suppliers in the Global Pharmaceutical Drug Development Services Category - Procurement Market Intelligence Report: IQVIA Inc, Laboratory Corp. of America Holdings, PAREXEL International Corp, ICON Plc, Syneos Health Inc, Pharmaceutical Product Development LLC.
Commenting on the report, an analyst from the author said: “One of the procurement best practices for buyers is to negotiate for performance-based contract instead of per hour contract.”
According to the report, one of the key growth contributors for the global pharmaceutical drug development services market is the rapid demand for specialty drugs.
Further, the report states that one of the key category management strategies for the buyers in the global pharmaceutical drug development services market is to collaborate with suppliers who adopt the latest technologies for drug development and reducing project delays.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains actionable insights to improve source-to-contract cycle performance in addition to a PESTLE analysis.
The author recognizes the following companies as the key suppliers in the Global Pharmaceutical Drug Development Services Category - Procurement Market Intelligence Report: IQVIA Inc, Laboratory Corp. of America Holdings, PAREXEL International Corp, ICON Plc, Syneos Health Inc, Pharmaceutical Product Development LLC.
Commenting on the report, an analyst from the author said: “One of the procurement best practices for buyers is to negotiate for performance-based contract instead of per hour contract.”
According to the report, one of the key growth contributors for the global pharmaceutical drug development services market is the rapid demand for specialty drugs.
Further, the report states that one of the key category management strategies for the buyers in the global pharmaceutical drug development services market is to collaborate with suppliers who adopt the latest technologies for drug development and reducing project delays.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains actionable insights to improve source-to-contract cycle performance in addition to a PESTLE analysis.
Table of Contents
PART 01: EXECUTIVE SUMMARY
PART 02: MARKET INSIGHTS
PART 03: CATEGORY PRICING INSIGHTS
PART 04: COST-SAVING OPPORTUNITIES
PART 05: BEST PRACTICES
PART 06: CATEGORY ECOSYSTEM
PART 07: CATEGORY MANAGEMENT STRATEGY
PART 08: CATEGORY MANAGEMENT ENABLERS
PART 09: SUPPLIERS SELECTION
PART 10: SUPPLIERS UNDER COVERAGE
PART 11: US MARKET INSIGHTS
PART 12: CATEGORY DEFINITION
PART 13: APPENDIX
Companies Mentioned
- IQVIA Inc
- Laboratory Corp. of America Holdings
- PAREXEL International Corp
- ICON Plc
- Syneos Health Inc
- Pharmaceutical Product Development LLC
Methodology
LOADING...